First-in-human Study With the Antibody-drug Conjugate SYD985 to Evaluate Safety and Efficacy in Cancer Patients
Clinical trial NCT02277717 · COMPLETED
Trial details
- NCT number
- NCT02277717
- Sponsor
- Byondis B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2019-01-01
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.